Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma, Follicular × Nivolumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 5 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Melanoma 3 Uveal Melanoma 2 Neoplasms 2 Lymphoma, B-Cell 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcopenia 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Lymphoma, Follicular 1 Gastrointestinal Stromal Tumors 1 Esophageal Squamous Cell Carcinoma 1 Efficacy, Team 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma 1 Carcinoma, Renal Cell 1 Bone Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

durvalumab 1 Sevoflurane 1 Rituximab 1 Radiotherapy 1 Propofol 1 Nivolumab 1 Massage 1 Ketamine 1 Fluorescence Polarization Immunoassay 1 Exercise 1 Echocardiography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03245021 2024-07-30

1stFLOR

Austin Health

Phase 1 Active not recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡